• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激素反应性和三阴性乳腺癌细胞系之间的稳定同位素分辨代谢组学差异

Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines.

作者信息

Winnike Jason H, Stewart Delisha A, Pathmasiri Wimal W, McRitchie Susan L, Sumner Susan J

机构信息

Analytical Sciences, David H. Murdock Research Institute, Kannapolis, NC 28081, USA.

NIH Eastern Regional Comprehensive Metabolomics Resource Core, Department of Nutrition, University of North Carolina at Chapel Hill Nutrition Research Institute, Kannapolis, NC 28081, USA.

出版信息

Int J Breast Cancer. 2018 Sep 30;2018:2063540. doi: 10.1155/2018/2063540. eCollection 2018.

DOI:10.1155/2018/2063540
PMID:30363973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6186330/
Abstract

PURPOSE

To conduct an exploratory study to identify mechanisms that differentiate Luminal A (BT474 and MCF-7) and triple-negative (MDA-MB-231 and MDA-MB-468) breast cancer (BCa) cell lines to potentially provide novel therapeutic targets based on differences in energy utilization.

METHODS

Cells were cultured in media containing either [U-C]-glucose or [U-C]-glutamine for 48 hours. Conditioned media and cellular extracts were analyzed by H and C NMR spectroscopy.

RESULTS

MCF-7 cells consumed the most glucose, producing the most lactate, demonstrating the greatest Warburg effect-associated energy utilization. BT474 cells had the highest tricarboxylic acid cycle (TCA) activity. The majority of energy utilization patterns in MCF-7 cells were more similar to MDA-MB-468 cells, while the patterns for BT474 cells were more similar to MDA-MB-231 cells. Compared to the Luminal A cell lines, TNBC cell lines consumed more glutamine and less glucose. BT474 and MDA-MB-468 cells produced high amounts of C-glycine from media [U-C]-glucose which was integrated into glutathione, indicating synthesis.

CONCLUSIONS

Stable isotopic resolved metabolomics using C substrates provided mechanistic information about energy utilization that was difficult to interpret using H data alone. Overall, cell lines that have different hormone receptor status have different energy utilization requirements, even if they are classified by the same clinical BCa subtype; and these differences offer clues about optimizing treatment strategies.

摘要

目的

进行一项探索性研究,以确定区分 Luminal A 型(BT474 和 MCF-7)和三阴性(MDA-MB-231 和 MDA-MB-468)乳腺癌(BCa)细胞系的机制,从而有可能基于能量利用差异提供新的治疗靶点。

方法

将细胞在含有[U-¹³C]-葡萄糖或[U-¹³C]-谷氨酰胺的培养基中培养48小时。通过¹H和¹³C核磁共振波谱分析条件培养基和细胞提取物。

结果

MCF-7 细胞消耗的葡萄糖最多,产生的乳酸最多,显示出与瓦伯格效应相关的最大能量利用。BT474 细胞具有最高的三羧酸循环(TCA)活性。MCF-7 细胞中的大多数能量利用模式与 MDA-MB-468 细胞更相似,而 BT474 细胞的模式与 MDA-MB-231 细胞更相似。与 Luminal A 型细胞系相比,三阴性乳腺癌细胞系消耗更多的谷氨酰胺和更少的葡萄糖。BT474 和 MDA-MB-468 细胞从培养基[U-¹³C]-葡萄糖中产生大量的¹³C-甘氨酸,这些甘氨酸整合到谷胱甘肽中,表明有合成过程。

结论

使用¹³C底物的稳定同位素分辨代谢组学提供了有关能量利用的机制信息,仅使用¹H数据难以解释这些信息。总体而言,具有不同激素受体状态的细胞系具有不同的能量利用需求,即使它们按相同的临床 BCa 亚型分类;这些差异为优化治疗策略提供了线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8d/6186330/5f977c9a7fa9/IJBC2018-2063540.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8d/6186330/6c812b22e9ce/IJBC2018-2063540.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8d/6186330/5f977c9a7fa9/IJBC2018-2063540.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8d/6186330/6c812b22e9ce/IJBC2018-2063540.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8d/6186330/5f977c9a7fa9/IJBC2018-2063540.002.jpg

相似文献

1
Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines.激素反应性和三阴性乳腺癌细胞系之间的稳定同位素分辨代谢组学差异
Int J Breast Cancer. 2018 Sep 30;2018:2063540. doi: 10.1155/2018/2063540. eCollection 2018.
2
Untargeted and stable isotope-assisted metabolomic analysis of MDA-MB-231 cells under hypoxia.缺氧条件下 MDA-MB-231 细胞的非靶向和稳定同位素辅助代谢组学分析。
Metabolomics. 2018 Feb 27;14(4):40. doi: 10.1007/s11306-018-1338-8.
3
Stable Isotope Tracing Reveals an Altered Fate of Glucose in -Acetyltransferase 1 Knockout Breast Cancer Cells.稳定同位素示踪技术揭示了乙酰基转移酶 1 敲除乳腺癌细胞中葡萄糖命运的改变。
Genes (Basel). 2023 Mar 31;14(4):843. doi: 10.3390/genes14040843.
4
Evaluation of MDA-MB-468 Cell Culture Media Analysis in Predicting Triple-Negative Breast Cancer Patient Sera Metabolic Profiles.评估MDA-MB-468细胞培养基分析在预测三阴性乳腺癌患者血清代谢谱中的作用。
Metabolites. 2020 Apr 27;10(5):173. doi: 10.3390/metabo10050173.
5
Metabolomics Profiling Reveals the Role of PEDF in Triple-Negative Breast Cancer Cell MDA-MB-231 under Glycaemic Loading.代谢组学分析揭示了色素上皮衍生因子(PEDF)在血糖负荷下三阴性乳腺癌细胞MDA-MB-231中的作用。
Pharmaceutics. 2023 Feb 6;15(2):543. doi: 10.3390/pharmaceutics15020543.
6
Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.激素反应性和三阴性乳腺癌细胞对紫杉醇反应的代谢组学分析确定关键代谢差异
J Proteome Res. 2016 Sep 2;15(9):3225-40. doi: 10.1021/acs.jproteome.6b00430. Epub 2016 Aug 3.
7
Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells.二甲双胍对雌激素和孕激素受体阳性(MCF-7)和三阴性(MDA-MB-231)乳腺癌细胞的影响。
Biomed Pharmacother. 2018 Jun;102:94-101. doi: 10.1016/j.biopha.2018.03.008. Epub 2018 Mar 15.
8
Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets.三种乳腺癌细胞系条件培养基的蛋白质组学分析:生物标志物和治疗靶点的宝库
Mol Cell Proteomics. 2007 Nov;6(11):1997-2011. doi: 10.1074/mcp.M600465-MCP200. Epub 2007 Jul 25.
9
CIP2A is a target of bortezomib in human triple negative breast cancer cells.CIP2A 是硼替佐米在人三阴性乳腺癌细胞中的作用靶点。
Breast Cancer Res. 2012 Apr 26;14(2):R68. doi: 10.1186/bcr3175.
10
Metabolic changes associated with methionine stress sensitivity in MDA-MB-468 breast cancer cells.与MDA-MB-468乳腺癌细胞中甲硫氨酸应激敏感性相关的代谢变化。
Cancer Metab. 2016 May 2;4:9. doi: 10.1186/s40170-016-0148-6. eCollection 2016.

引用本文的文献

1
Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis.基于代谢组学的乳腺癌预后和诊断生物标志物发现
Cells. 2024 Dec 25;14(1):5. doi: 10.3390/cells14010005.
2
Macropinocytosis mediates resistance to loss of glutamine transport in triple-negative breast cancer.巨吞饮作用介导三阴性乳腺癌对谷氨酰胺转运丧失的抗性。
EMBO J. 2024 Dec;43(23):5857-5882. doi: 10.1038/s44318-024-00271-6. Epub 2024 Oct 17.
3
Mapping endocrine networks by stable isotope tracing.通过稳定同位素示踪绘制内分泌网络。

本文引用的文献

1
Clinical Characteristics in Patients with Triple Negative Breast Cancer.三阴性乳腺癌患者的临床特征
Int J Breast Cancer. 2017;2017:1796145. doi: 10.1155/2017/1796145. Epub 2017 Aug 17.
2
Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.激素反应性和三阴性乳腺癌细胞对紫杉醇反应的代谢组学分析确定关键代谢差异
J Proteome Res. 2016 Sep 2;15(9):3225-40. doi: 10.1021/acs.jproteome.6b00430. Epub 2016 Aug 3.
3
GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity.
Curr Opin Endocr Metab Res. 2022 Oct;26:100381. doi: 10.1016/j.coemr.2022.100381.
4
Five-year survival in luminal breast cancer patients: relation with intratumoral activity of proteasomes.管腔型乳腺癌患者的五年生存率:与肿瘤内蛋白酶体活性的关系
Transl Breast Cancer Res. 2022 Jul 30;3:23. doi: 10.21037/tbcr-22-22. eCollection 2022.
5
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer.野生型异柠檬酸脱氢酶2是三阴性乳腺癌的一个治疗靶点。
Nat Commun. 2024 Apr 24;15(1):3445. doi: 10.1038/s41467-024-47536-6.
6
L. modulates altered metabolic pathways involved in key metabolisms in human breast cancer (MCF-7) cells: A metabolomics study.L.调节参与人乳腺癌(MCF-7)细胞关键代谢的改变的代谢途径:一项代谢组学研究。
Heliyon. 2023 May 9;9(5):e16156. doi: 10.1016/j.heliyon.2023.e16156. eCollection 2023 May.
7
Multi-omics analyses reveal ClpP activators disrupt essential mitochondrial pathways in triple-negative breast cancer.多组学分析揭示ClpP激活剂破坏三阴性乳腺癌中的关键线粒体途径。
Front Pharmacol. 2023 Mar 31;14:1136317. doi: 10.3389/fphar.2023.1136317. eCollection 2023.
8
Simultaneous glutamine metabolism and PD-L1 inhibition to enhance suppression of triple-negative breast cancer.同时抑制谷氨酰胺代谢和 PD-L1 以增强对三阴性乳腺癌的抑制作用。
J Nanobiotechnology. 2022 May 6;20(1):216. doi: 10.1186/s12951-022-01424-7.
9
Impact of the PdSpm (Spermine) Complex on the Metabolism of Triple-Negative Breast Cancer Tumors of a Xenograft Mouse Model.PdSpm(精脒)复合物对异种移植小鼠模型三阴性乳腺癌肿瘤代谢的影响。
Int J Mol Sci. 2021 Oct 5;22(19):10775. doi: 10.3390/ijms221910775.
10
Worm-Based Microfluidic Biosensor for Real-Time Assessment of the Metastatic Status.用于实时评估转移状态的基于蠕虫的微流控生物传感器
Cancers (Basel). 2021 Feb 19;13(4):873. doi: 10.3390/cancers13040873.
GSTP1 是三阴性乳腺癌细胞代谢和发病机制的驱动因素。
Cell Chem Biol. 2016 May 19;23(5):567-578. doi: 10.1016/j.chembiol.2016.03.017. Epub 2016 May 12.
4
Neuroglobin in Breast Cancer Cells: Effect of Hypoxia and Oxidative Stress on Protein Level, Localization, and Anti-Apoptotic Function.乳腺癌细胞中的神经球蛋白:缺氧和氧化应激对蛋白质水平、定位及抗凋亡功能的影响
PLoS One. 2016 May 5;11(5):e0154959. doi: 10.1371/journal.pone.0154959. eCollection 2016.
5
Breast cancer statistics, 2015: Convergence of incidence rates between black and white women.乳腺癌统计数据,2015:黑人和白人女性发病率趋同。
CA Cancer J Clin. 2016 Jan-Feb;66(1):31-42. doi: 10.3322/caac.21320. Epub 2015 Oct 29.
6
Glutamate enrichment as new diagnostic opportunity in breast cancer.谷氨酸富集作为乳腺癌新的诊断契机。
Int J Cancer. 2015 Apr 1;136(7):1619-28. doi: 10.1002/ijc.29152. Epub 2014 Sep 4.
7
Techniques to monitor glycolysis.监测糖酵解的技术。
Methods Enzymol. 2014;542:91-114. doi: 10.1016/B978-0-12-416618-9.00005-4.
8
Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.三阴性乳腺癌非洲裔美国女性的结局差异:三阴性乳腺癌非洲裔美国女性与白人女性的流行病学和分子因素比较
BMC Cancer. 2014 Feb 4;14:62. doi: 10.1186/1471-2407-14-62.
9
Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women.乳腺癌亚型对青少年及年轻成年女性3年生存率的影响。
Breast Cancer Res. 2013;15(5):R95. doi: 10.1186/bcr3556.
10
Neoadjuvant therapy in operable breast cancer: application to triple negative breast cancer.可手术乳腺癌的新辅助治疗:在三阴性乳腺癌中的应用。
J Oncol. 2013;2013:219869. doi: 10.1155/2013/219869. Epub 2013 Aug 1.